On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and CEO Dave Ricks ... on out ...

BioCrossroads has named Eli Lilly CEO, Dave Ricks, the recipient of the 2024 August M. Watanabe Life Sciences Champion of the ...

Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...

Fall is the time to wander the back roads of southern Indiana, driving the hills and hollows of Brown County, through long ...

Articles, podcasts and YouTube videos are complimentary from those helping preserve our history: Eagle Communications, ...

Lilly Limerick is set to be the global pharmaceutical leader's most technically advanced manufacturing site to date ...

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment ...

Eli Lilly (NYSE:LLY) shares fell ~9% in the premarket on Wednesday, sending ADRs of its rival Novo Nordisk (NVO) lower after the U.S. drugmaker missed Street forecasts with its Q3 2024 financials ...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker on Wednesday chopped a ...

Eli Lilly has a long history of developing drugs to treat a variety of conditions. For example, its third-best-selling drug Verzenio is used to help treat breast cancer, while its sixth-best ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks featured in Jim Cramer’s latest game plan. Jim Cramer, the host of Mad ...